Elizabeth W. LaPensee

Treatment-Dependent Androgen Receptor Mutations in Prostate Cancer Exploit Multiple Mechanisms to Evade Therapy

Mara P. Steinkamp, Orla A. O’Mahony, Michele Brogley et al. · Cancer Research · 2009 · 205 citations · Full text

Bisphenol A at Low Nanomolar Doses Confers Chemoresistance in Estrogen Receptor-α–Positive and –Negative Breast Cancer Cells

Elizabeth W. LaPensee, Traci R. Tuttle, Sejal R. Fox et al. · Environmental Health Perspectives · 2008 · 134 citations · Full text

Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase

Elizabeth W. LaPensee, Sandy Schwemberger, Christopher R. LaPensee et al. · Carcinogenesis · 2009 · 63 citations · Full text

Bisphenol A and estradiol are equipotent in antagonizing cisplatin-induced cytotoxicity in breast cancer cells

Elizabeth W. LaPensee, Christopher R. LaPensee, Sejal R. Fox et al. · Cancer Letters · 2009 · 50 citations

Breast Oncology, Medicine, Breast Cancer Cells +10

Differential modulation of the androgen receptor for prostate cancer therapy depends on the DNA response element

Steven Kregel, Pia Bagamasbad, Shihan He et al. · Nucleic Acids Research · 2020 · 32 citations · Full text

Prostate Cancer Therapy, Androgen Receptor, Cell Cycle Genes +14